Healthcare & Medical Investment, 3% Decrease in Ordinary Profit for The Current Fiscal Year

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Sep 13, 2024 3:30 pm JST Earnings

3455 Healthcare & Medical Investment

Earnings Report

Healthcare & Medical Investment <3455> [TSE-REIT] announced its financial results after the market closed on September 13th (15:30). ordinary profit for the fiscal year ending July 2024 was 0.5% from the previous period to 1.05 billion yen. However, for the fiscal year ending January 2025, the profit is expected to decrease by 3.0% from the previous period to 1.02 billion yen.

At the same time, the company increased the distribution for the previous term from 3235 yen to 3261 yen (compared to 3235 yen in the prior term), and plans to set the distribution for the current term at 3175 yen.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2023	2,438	1,268	1,068	1,068	2,970.0	3,282	Sep 15, 2023	J-GAAP
Jan, 2024	2,438	1,254	1,050	1,049	2,919.0	3,235	Mar 19, 2024	J-GAAP
Jul, 2024	2,514	1,298	1,055	1,054	2,934.0	3,261	Sep 13, 2024	J-GAAP
YoY	+3.1%	+3.5%	+0.5%	+0.5%	+0.5%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2024 Guidance	2,514	1,290	1,046	1,045	2,906.8	3,235	Mar 19, 2024	J-GAAP
Jul, 2024 Results	2,514	1,298	1,055	1,054	2,934.0	3,261	Sep 13, 2024	J-GAAP
Revision Rate	0.0%	+0.6%	+0.9%	+0.9%	+0.9%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2024	2,438	1,254	1,050	1,049	2,919.0	3,235	Mar 19, 2024	J-GAAP
Jul, 2024	2,514	1,298	1,055	1,054	2,934.0	3,261	Sep 13, 2024	J-GAAP
Jan, 2025 Guidance	2,515	1,272	1,023	1,022	2,842.8	3,175	Sep 13, 2024	J-GAAP
YoY	+0.0%	-2.0%	-3.0%	-3.0%	-3.1%

Quarterly Results